Our New Website Is Here!
As part of our merger with St. Paul Research, we’ve created a new website that will house all of our collective content under one roof, bringing you a higher level of research and service through our analysts’ combined insight, expertise, and perspective. Go to my.stpaulresearch.com to access our new site.

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now...

In Breakthrough Technology Alert, Ray Blanco tirelessly researches these exciting new breakthrough technologies and tells you exactly what you need to do to profit from them.

NanoViricides Shows Oral Delivery and Anavex Benefits as Field of AD Drugs Narrows

I have truly astounding news from NanoViricides (OTCBB: NNVC). First, however, allow me to respond to a friend who told me recently that I should have reminded my readers that I had predicted the failure of bapineuzumab, the Alzheimer's drug candidate jointly funded by Pfizer, Johnson & Johnson and Elan.

So for the record, I told you so.

In fact, the reason I got this right was that I listened to Dr. Cameron Durrant, formerly a top executive for several Big Pharma companies and Anavex Life Sciences Corp. (OTCBB: AVXL). Durrant knows the inside story when it comes to AD as well as the pharmaceutical industry.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!


Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.

LoginGet Access

Patrick Cox

Patrick Cox has lived deep inside transformative technologies for over 25 years. In the 1980s, he worked in software development and manufacturing. By the mid-‘90s, he consulted for Netscape–which handled 90% of all Internet browsing traffic at the time. InfoWorld and USA Today have featured his research, and he’s written for The Wall Street Journal,...

View More By Patrick Cox